![](img/space.gif) |
In vivo and in vitro investigation of hemostasis in acute stroke patients treated with iv. thrombolysis and mechanical thrombectomy
|
Help
Print
|
Here you can view and search the projects funded by NKFI since 2004
Back »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
List of publications |
|
|
Bagoly Z, Baráth B, Orbán-Kálmándi R, Szegedi I, Bogáti R, Sarkady F, Csiba L, Katona É.: Incorporation of Alpha2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients., Biomolecules 2021;11: 347. doi: 10.3390/biom11030347, 2021 | Arokszallasi Tamas, Balogh Eszter, Csiba Laszlo, Fekete Istvan, Fekete Klara, Olah Laszlo: Acute alcohol intoxication may cause delay in stroke treatment - case reports, BMC NEUROLOGY 19: 14, 2019 | Bagoly Zsuzsa, Hajas Orsolya, Urbancsek Réka, Kiss Alexandra, Fiak Edit, Sarkady Ferenc, Tóth Noémi Klára, Orbán-Kálmándi Rita, Kovács Kitti Bernadett, Nagy László, Nagy Attila, Kappelmayer János, Csiba László, Csanádi Zoltán: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists..., JOURNAL OF CLINICAL MEDICINE 9: (9) 3050, 2020 | Szegedi István, Orbán-Kálmándi Rita, Csiba László, Bagoly Zsuzsa: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature, JOURNAL OF CLINICAL MEDICINE 9: (10) 3137, 2020 | Orbán-Kálmándi R, Szegedi I, Sarkady F, Fekete I, Fekete K, Vasas N, Berényi E, Csiba L, Bagoly Z.: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis., Sci Rep. 2021;11(1):12713. doi: 10.1038/s41598-021-92041-1., 2021 | Bagoly Z, Baráth B, Orbán-Kálmándi R, Szegedi I, Bogáti R, Sarkady F, Csiba L, Katona É.: Incorporation of Alpha2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients., Biomolecules 2021;11: 347. doi: 10.3390/biom11030347, 2021 | Hudák L, Nagy A, Molnár S, Méhes G, Nagy KE, Oláh L, Csiba L.: Discrepancies between clinical and autopsy findings in patients who had an acute stroke, Stroke and Vasc Neurol, doi: 10.1136/svn-2021-001030, 2021 | Szegedi István: Fibrinolítikus paraméterek és az alvadék méretének összefüggései az intravénás trombolízis sikerességével iszkémiás stroke-ot szenvedett betegekben, Debreceni Egyetem, Laki Kálmán Doktori Iskola PhD tézis, 2021, https://dea.lib.unideb.hu/dea/handle/2437/323240, 2021 | Orbán-Kálmándi Rita Angéla: In vitro alvadék lízis vizsgálatok az akut iszkémiás és a vérzéses stroke kimenetelének megítélésére, Debreceni Egyetem, Laki Kálmán Doktori Iskola PhD tézis, 2021, https://dea.lib.unideb.hu/dea/handle/2437/325761, 2021 | Baráth Barbara: Az α2-plazmin inhibitor szerepének vizsgálata trombotikus megbetegedésekben, Debreceni Egyetem, Laki Kálmán Doktori Iskola PhD tézis, 2021, https://dea.lib.unideb.hu/dea/handle/2437/321320, 2021 | R. Orbán-Kálmándi, B. Baráth, F. Sarkady, E. Székely, I. Szegedi, K.R. Czuriga-Kovács, I. Fekete, K. Fekete, É. Katona, L. Csiba, Z. Bagoly: Low α2-plasmin inhibitor antigen levels on admission predict unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis, ISTH 2020 Congress oral presentation, 2020 | R. Orbán-Kálmándi, F. Sarkady, I. Szegedi, I. Fekete, K. Fekete, L. Csiba, Z. Bagoly: Elevated levels of circulating markers of neutrophil extracellular traps (NETs) are associated with unfavorable outcomes in acute ischemic stroke patients undergoing intr, ISTH 2020 Virtual Congress, 2020 | Szegedi I, Orbán-Kálmándi R, Nagy A, Sarkady F, Vasas N, Sik M, Lánczi LI, Berényi E, Oláh L, Crișan A, Csiba L, Bagoly Z.: Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous throm, PLoS One, 2021;16(7):e0254253. doi: 10.1371/journal.pone.0254253, 2021 | Orbán-Kálmándi R, Szegedi I, Sarkady F, Fekete I, Fekete K, Vasas N, Berényi E, Csiba L, Bagoly Z.: A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis., Sci Rep. 2021;11(1):12713. doi: 10.1038/s41598-021-92041-1., 2021 | R. Kálmándi, I. Szegedi, I. Fekete, K. Fekete, F. Sarkady, L. Varga, L. Csiba, Z. Bagoly: The Use of In Vitro Clot Lysis Assay For Predicting Outcomes and Safety In Acute Ischemic Stroke Patients Undergoing Intravenous Thrombolysis, ECTH abstract, 2019 | Tamás Árokszállási, Zsuzsa Bagoly, István Fekete, Klára Fekete, István Szegedi, Judit Tóth, Mónika Andrejkovics, Tibor Hortobágyi, László Csiba: HEMOSTASIS BIOMARKERS IN THE PROGNOSIS OF NON-TRAUMATIC INTRACEREBRAL HEMORRHAGE, ESOC abstract 2019, 2019 | I. Szegedi, T. Árokszállási, I. Fekete, K. Fekete, A. Nagy, F. Sarkady, E.G. Székely, K.R. Czuriga-Kovács, E. Berényi, Z. Bagoly, L. Csiba.: THE ASSOCIATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) 4G/5G POLYMORPHISM WITH THE RISK AND PROGNOSIS OF INTRACEREBRAL HEMORRHAGE, ESOC 2019, 2019 | Tóth Noémi Klára: A VIII-as faktor és a von Willebrand faktor szintek vizsgálata pitvarfibrilláló és ischaemiás stroke-on átesett betegekben, Debreceni Egyetem, Laki Kálmán Doktori Iskola PhD tézis, 2019 | Bagoly Zsuzsa, Hajas Orsolya, Urbancsek Réka, Kiss Alexandra, Fiak Edit, Sarkady Ferenc, Tóth Noémi Klára, Orbán-Kálmándi Rita, Kovács Kitti Bernadett, Nagy László, Nagy Attila, Kappelmayer János, Csiba László, Csanádi Zoltán: Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists..., JOURNAL OF CLINICAL MEDICINE 9: (9) 3050, 2020 | Hajas Orsolya, Bagoly Zsuzsa, Tóth Noémi Klára, Urbancsek Réka, Kiss Alexandra, Kovács Kitti B, Sarkady Ferenc, Nagy Attila, V. Oláh Anna, Nagy László, Clemens Marcell, Csiba László, Csanádi Zoltán: Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques, CARDIOLOGY RESEARCH AND PRACTICE 2020: 1570483, 2020 | Majer Réka, Adeyi Olar, Bagoly Zsuzsa, Simon Viktória, Csiba László, Kardos László, Hortobágyi Tibor, Frecska Ede: Neuropsychiatric symptoms, quality of life and caregivers’ burden in dementia, OPEN MEDICINE 15: (1) pp. 905-914., 2020 | Szegedi István, Orbán-Kálmándi Rita, Csiba László, Bagoly Zsuzsa: Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature, JOURNAL OF CLINICAL MEDICINE 9: (10) 3137, 2020 | Szegedi I, Szapáry L, Csécsei P, Csanádi Z, Csiba L.: Potential biological markers of atrial fibrillation: a chance to prevent cryptogenic stroke, Biomed Res Int. 2017:8153024, 2017 | Tóth NK, Csanádi Z, Hajas O, Kiss A, Nagy-Baló E, Kovács KB, Sarkady F, Muszbek L, Bereczky Z, Csiba L, Bagoly Z: Intracardiac hemostasis and fibrinolysis parameters in patients with atrial fibrillation, Biomed Res Int 2017;3678017, 2017 | Hudák R, Székely EG, Kovács KR, Nagy A, Hofgárt G, Berényi E, Csiba L, Kappelmayer J, Bagoly Z: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis, PLoS One, 2017 | Bagoly Z, Hudák R, Székely EG, Kovács KR, Nagy A, Hofgárt G, Berényi E, Kappelmayer J, Csiba L.: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis, Eur Stroke J; 2(IS):72, 2017 | Hofgárt G, Tóth NK, Crisan A, Székely EG, Kovács KR, Berényi E, Bagoly Z, Csiba L.: Association of D-dimer levels before and during thrombolysis with the outcome of therapy in ischemic stroke patients, ESOC 2017, 2017 | Hudák R, Székely EG, Kovács KR, Nagy A, Hofgárt G, Berényi E, Csiba L, Kappelmayer J, Bagoly Z: Low thrombin generation predicts poor prognosis in ischemic stroke patients after thrombolysis, PLoS One 2017; 12:e0180477, 2017 | Szegedi I, Székely EG, Czuriga-Kovács KR, Nagy A, Sarkady F, Lánczi LI, Berényi E, Bagoly Z, Csiba L..: The role of plasminogen activator inhibitor 1 (PAI-1) levels and PAI-1 4G/5G polymorphism in the outcome of intravenous thrombolytic therapy in ischemic stroke patients, Res Pract Thromb Haemost; 2018; (2)S2:153., 2018 | Bagoly Z, Baráth B, Szegedi I, Kálmándi R, Csiba L, Katona É.: The effect of factor XIII levels on the incorporation of alpha2PI into fibrin clots: association with the therapeutic outcome of acute ischemic stroke patients, Res Pract Thromb Haemost; (2) Suppl2:198, 2018 | Bagoly Z, Tóth NK, Székely EG, Czuriga-Kovács KR, Sarkady F, Nagy O, Lánczi LI, Berényi E, Fekete K, Fekete I, Szegedi I, Csiba L.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis, Eur Stroke J 2018; 3(IS): 144., 2018 | Szegedi I, Székely EG, Czuriga-Kovács KR, Nagy A, Sarkady F, Lánczi LI, Berényi E, Bagoly Z, Csiba L..: The role of plasminogen activator inhibitor 1 (PAI-1) levels and PAI-1 4G/5G polymorphism in the outcome of intravenous thrombolytic therapy in ischemic stroke patients, Eur Stroke J 2018; 3(IS): 145, 2018 | Székely EG, Czuriga-Kovács KR, Bereczky Z, Katona É, Mezei ZA, Nagy A, Tóth NK, Berényi E, Muszbek L, Csiba L, Bagoly Z.: Low factor XIII levels after intravenous thrombolysis predict short-term mortality in ischemic stroke patients, Scientific Reports 2018; 8: e7662. doi:10.1038/s41598-018-26025, 2018 | Tóth NK, Székely EG, Czuriga-Kovács KR, Sarkady F, Nagy O, Lánczi LI, Berényi E, Fekete K, Fekete I, Csiba L, Bagoly Z.: Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis, Frontiers in Neurology 2018; 8:e721, doi:10.3389/fneur.2017.00721, 2018 | Arokszallasi Tamas, Balogh Eszter, Csiba Laszlo, Fekete Istvan, Fekete Klara, Olah Laszlo: Acute alcohol intoxication may cause delay in stroke treatment - case reports, BMC NEUROLOGY 19: 14, 2019 | Bagoly Zsuzsa, Szegedi Istvan, Kalmandi Rita, Toth Noemi Klara, Csiba Laszlo: Markers of Coagulation and Fibrinolysis Predicting the Outcome of Acute Ischemic Stroke Thrombolysis Treatment: A Review of the Literature, FRONTIERS IN NEUROLOGY 10: 513, 2019 | Balogh Eszter, Árokszállási Tamás, Csiba László, Oláh László: Effect of reading with direct or indirect light on the visually evoked flow response in the posterior cerebral artery, JOURNAL OF CLINICAL ULTRASOUND 47: (5) pp. 272-277., 2019 | Csikai E., Andrejkovics M., Balajthy-Hidegh B., Hofgárt G., Kardos L., Diószegi Á., Rostás R., Czuriga-Kovács K.R., Csongrádi É., Csiba L.: Influence of angiotensin-converting enzyme inhibition on reversibility of alterations in arterial wall and cognitive performance associated with early hypertension, MEDICINE 98: (34) p. e16966., 2019 | Czuriga‐Kovács Katalin R., Czuriga Dániel, Kardos László, Soltész Pál, Csiba László: Reply to letter: Reversibility of hypertension‐induced subclinical vascular changes: Do the new ACC/AHA 2017 blood pressure guidelines and heart rate changes make a difference?, JOURNAL OF CLINICAL HYPERTENSION 21: (8) pp. 1243-1244., 2019 | Czuriga‐Kovács Katalin Réka, Szekeres Csilla Cecília, Bajkó Zoltán, Csapó Krisztina, Oláh László, Magyar Mária Tünde, Molnár Sándor, Czuriga Dániel, Kardos László, Bojtor Burainé Andrea, Bereczki Dániel, Soltész Pál, Csiba László: Hypertension‐induced subclinical vascular and cognitive changes are reversible—An observational cohort study, JOURNAL OF CLINICAL HYPERTENSION 21: (5) pp. 658-667., 2019 | Szegedi I, Nagy A, Székely EG, Czuriga-Kovács KR, Sarkady F, Lánczi IL, Berényi E, Csiba L, Bagoly Z: PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients, ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY 2019: doi: 10.1002/ACN3.50923, 2019 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif)
Back »
|
![](img/space.gif) |
|